NL-OMON54864招募中不适用
IgA-based immunotherapy development and evaluation using the blood of healthy volunteers - INVOLVE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy individual, 18-55 years of age, bodyweight: above 50 kg. Being able and
- •willing to complete the informed consent process.
排除标准
- •Known to be infected with HIV, syphilis, tuberculosis, hepatitis B or hepatitis
- •A condition in which blood draw poses more than minimal risk for the subject
- •such as hemophilia, other severe coagulation disorders or significantly
- •impaired venous access.
- •A condition that requires active medical intervention or monitoring to avert
- •serious danger to the participant's health or well-being.
- •IgA deficiency, as well as rheumatoid arthritis and other chronic inflammatory
- •conditions.
研究者
相似试验
招募中
2 期
Efficacy stem cells in improving the symptoms of patients with lupusSystemic lupus erythematosus.Systemic lupus erythematosus (SLE)IRCT20130812014333N182Kermanshah University of Medical Sciences20
尚未招募
1 期
Gastric cancer immunotherapygastric cancer.Malignant neoplasm of stomachIRCT20170208032451N1Mashhad University of Medical Sciences5
已完成
1 期
Assessment of efficacy and safety of immunotherapy for unresectable locally advanced pancreatic cancer.pancreatic ductal carcinomaJPRN-UMIN000000769agoya University Hospital15
尚未招募
不适用
An integrated immunological-pharmacological approach to improve long-term allograft functiograft failurekidney transplantation10029149NL-OMON45414Inwendige Geneeskunde - Nefrologie en Transplantatie420
已完成
不适用
Een fase I/II vaccinatie studie met patient eigen dendritische cellen geladen met TAT, REV en NEF mRNA in HIV geïnfecteerden tijdens stabiele HAART.HIV-1 infection, seroposoitive anti-retroviral treatment, cellular immunity, early proteins, Tat, Rev, NefNL-OMON25488Erasmus MC, Rotterdam, Vrije Universiteit Brussel, BrusselK.Thielemans, MD, PhD Director Laboratory of Molecular and Cellular Therapy Medical School Vrije Universiteit BrusselLaarbeeklaan 103 B-1090 BrusselsTel: + 32 (0)2 477 45 69Fax: + 32 (0)2 477 45 68e-mail: Kris.Thielemans@vub.ac.be17